Understanding and adhering to 21 CFR Part 11 compliance is crucial to industries regulated by the FDA. This page explores what 21 CFR Part 11 compliance entails, the industries that require it, FDA rules and regulations and how eSignature solutions can comply.
21 CFR Part 11 is a set of regulations established by the U.S. Food and Drug Administration (FDA) that define the criteria under which electronic records and electronic signatures are considered trustworthy, reliable and equivalent to paper records and handwritten signatures. These regulations aim to ensure that electronic documents are secure, authenticated and stored with integrity.
To be compliant with 21 CFR Part 11, the FDA requires adherence to several key regulations
System Validation
Systems managing electronic records must be validated to ensure accuracy, reliability and consistent performance.
Audit Trails
Secure, computer-generated, time-stamped audit trails must be implemented to record all modifications to electronic records.
Electronic Signatures
Electronic signatures must be unique to each individual and verified to ensure authenticity.
Record Retention
Electronic records must be stored and retrievable in a compliant format for the required retention period.
Copies of Records
Copies of records should be maintained for inspection purposes.
Please visit the FDA published guideline to learn more about electronic signatures and records.
If you're interested in discussing how DocuSeal can accommodate your specific regulatory needs or if you have any questions about 21 CFR Part 11 compliance, feel free to contact our sales team.